Skip to main content
Article thumbnail
Location of Repository

The Treatment of Melioidosis

By Timothy J.J. Inglis

Abstract

Melioidosis is a complex bacterial infection, treatment of which combines the urgency of treating rapidly fatal Gram negative septicaemia with the need for eradication of long-term persistent disease in pulmonary, soft tissue, skeletal and other organ systems. Incremental improvements in treatment have been made as a result of multicentre collaboration across the main endemic region of Southeast Asia and northern Australia. There is an emerging consensus on the three main patterns of antimicrobial chemotherapy; initial (Phase 1) treatment, subsequent eradication (Phase 2) therapy and most recently post-exposure (Phase 0) prophylaxis. The combination of agents used, duration of therapy and need for adjunct modalities depends on the type, severity and antimicrobial susceptibility of infection. New antibiotic and adjunct therapies are at an investigational stage but on currently available data are unlikely to make a significant impact on this potentially fatal infection

Topics: melioidosis, treatment, antibiotics, adjunct therapy, Pharmacy and materia medica, RS1-441, Medicine, R, DOAJ:Pharmacy and materia medica, DOAJ:Medicine (General), DOAJ:Health Sciences
Publisher: MDPI AG
Year: 2010
DOI identifier: 10.3390/ph3051296
OAI identifier: oai:doaj.org/article:16a1108523d247dcb277a24e9235b51c
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1424-8247 (external link)
  • http://www.mdpi.com/1424-8247/... (external link)
  • https://doaj.org/article/16a11... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.